Novartis to Acquire UK-Based Myricx Bio in Deal Worth Up to $1.5 Billion
Swiss Drugmaker Expands Cancer Portfolio With Next-Generation Antibody-Drug Conjugate Technology Swiss pharmaceutical giant Novartis has agreed to acquire UK biotechnology ...
Swiss Drugmaker Expands Cancer Portfolio With Next-Generation Antibody-Drug Conjugate Technology Swiss pharmaceutical giant Novartis has agreed to acquire UK biotechnology ...
I don’t want startup news.
I don’t want startup news.